Allogeneic Mesenchymal Stem Cells for the Survivors of Ischemic Stroke Trial (ASSIST)
Status:
Not yet recruiting
Trial end date:
2023-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability, and preliminary efficacy
of single injection of it-hMSC in patients with ischemic stroke in a multicenter, blind,
randomized, placebo controlled trial